Since GOLT1A was shown as a candidate miR-378a-3p target in breast cancer cells, we investigated whether a negative correlation between miR-378a-3p and GOLT1A expression can be observed in clinical breast cancer specimens (Fig. 5a). The gene discussed is GOLT1A; the disease is breast cancer.